Mark D. Chatfield

Mark D. Chatfield is an Associate Professor and biostatistician at the University of Queensland's School of Health and Rehabilitation Sciences and UQ Clinical Trials Centre. With over 20 years of experience in Australia (Brisbane, Darwin, Sydney) and the UK (Cambridge, 2002-2009), he collaborates extensively with health and medical researchers across multiple disciplines. He also holds an Honorary Fellow (Associate Professor) position with Menzies School of Health Research.

Dr. Chatfield specializes in biostatistics and clinical trials methodology, with research interests spanning statistical analysis for medical research, epidemiology, infectious disease modeling, and data visualization. His work frequently involves developing and applying advanced statistical techniques to address complex health issues, particularly in Indigenous health, pediatric care, and infectious diseases. He has made significant contributions to statistical methodology, including the widely used table1_mc command for Stata users worldwide.

His publication record is extensive, with over 200 journal articles spanning diverse medical fields. Recent work shows a strong focus on clinical trials methodology, Indigenous health outcomes, pediatric development, and infectious disease epidemiology. He frequently collaborates on multicenter international trials, particularly those addressing health disparities in vulnerable populations.

Dr. Chatfield has secured substantial research funding, serving as an investigator on 30 NHMRC/MRFF-funded studies totaling over $57 million, primarily clinical trials. He actively contributes to the Australian Clinical Trials Alliance Statistics in Trials Interest Group, helping to shape best practices in clinical trial design and analysis.

As an academic mentor, he has co-supervised 6 PhD students to completion and currently advises 3 additional PhD students. His methodological expertise is highly sought after across multiple research disciplines at the University of Queensland and beyond.